Clinical trials
Withdrawn Phase 2 Leukemia, Lymphocytic, Chronic, B-Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2002 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 3 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 3 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 36 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoag Memorial Hospital Presbyterian | 3 |
| Fred Hutchinson Cancer Center | 2 |
| M.D. Anderson Cancer Center | 2 |
| Masonic Cancer Center, University of Minnesota | 2 |
| University of California, San Diego | 2 |
| Abbott | 1 |
| Academic and Community Cancer Research United | 1 |
| AstraZeneca | 1 |
| Baptist Health South Florida | 1 |
| City of Hope Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Lymphocytic, Chronic, B-Cell | 36 |
| Leukemia | 10 |
| Lymphoma, B-Cell, Marginal Zone | 10 |
| Lymphoma, Non-Hodgkin | 9 |
| Lymphoma | 8 |
| Lymphoma, Follicular | 8 |
| Lymphoma, Mantle-Cell | 8 |
| Burkitt Lymphoma | 6 |
| Lymphoma, Large B-Cell, Diffuse | 6 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 6 |
Trials
Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.